November is both Pancreatic Cancer Awareness Month and Lung Cancer Awareness Month, and both hit close to home for me. When we get our genetic test results, the conversation usually centers on a few organs, while other risks become a footnote or never come up at all.
In this episode, I share my dad’s pancreatic cancer story, including how clinical trials gave him about three more years, and why I wonder what genetic testing might have meant for our family. I also talk about my grandfather’s lung cancer and the question of what we can and can’t know about his story.
We cover hereditary pancreatic cancer risk across gene mutations like BRCA1, BRCA2, PALB2, ATM, TP53, and Lynch syndrome, plus the symptoms to bring up with your doctor and what pancreatic cancer surveillance looks like. I also share why I’m starting surveillance myself in January.
Then we turn to lung cancer and what researchers are still learning about its possible connection to inherited mutations. There are no clear answers or screening guidelines based on these mutations yet, so we talk about what we do know, including radon testing, the difference between biomarker testing and genetic testing, and my own experience with lung nodules.
Whether you’re a previvor, a survivor, or supporting someone you love, this episode is a reminder that your whole body deserves to be part of the conversation.
Resources mentioned:
Connect with BRCA & Beyond:
This podcast shares personal stories and experiences for informational and inspirational purposes only. It does not replace medical advice, diagnosis, or treatment. Always consult your own doctor or healthcare provider before making any medical decisions.
","author_name":"Marisa Stachelski, Cancer Survivor & BRCA2 Previvor"}